Pediatrics 117:923–929PubMedCrossRef Gurian EA, Kinnamon DD, Henr

Pediatrics 117:923–929PubMedCrossRef Gurian EA, Kinnamon DD, Henry AZD6244 manufacturer JJ, Waisbren SE (2006) Expanded newborn Fosbretabulin solubility dmso screening for biochemical disorders: the effect of a false-positive results. Pediatrics 117:1915–1921PubMedCrossRef Guthrie R, Susi A (1963) A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics 32:338–343PubMed Hansen H (1975) Prevention of mental retardation due to PKU: selected aspects of program validity. Prev Med 4:310–321PubMedCrossRef Health and Disability Commissioner. A Report by the Health and Disability Commissioner. Opinion on Case 04HDC14171, 1 June 2005, Accessed online October 2011

http://​www.​hdc.​org.​nz/​decisions–case-notes/​commissioner’s-decisions/​2005/​04hdc14171 Hewlett J, Waisbren SE (2006) A review of the psychosocial effects of false-positive results on parents and current communication practices in newborn screening. J Inherit Metab Dis 29:677–682PubMedCrossRef Hill RE (1993) The diagnosis of inborn errors of metabolism by examination of the genotype. Clin Chim Acta 217:3–14PubMedCrossRef Howell R (2006) We need expanded newborn screening. Pediatrics 117:1800–1805PubMedCrossRef Human Genetics Society of Australasia (2011) Newborn bloodspot screening. Joint policy statement of HGSA-RACP, August 2011. Accessed online January 2012 at https://​www.​hgsa.​org.​au/​website/​wp-content/​uploads/​2011/​08/​2011P02-Newborn-Bloodspot-Screening1.​pdf

Jones PM, Bennett MJ (2002) The changing face of newborn screening: diagnosis of inborn errors of metabolism by tandem mass spectrometry. Clin Chim Acta 324:121–128PubMedCrossRef Li Y, Scott CR, LGX818 molecular weight Megestrol Acetate Chamoles NA, Ghavami A et al (2004) Direct multiplex assay of lysosomal enzymes in dried blood spots for newborn screening. Clin Chem 50:1785–1796PubMedCrossRef Lin B, Fleischman A (2008) Another voice—screening and caring for children with rare disorders. Hast Cent Rep 38:3 Meikle PJ, Grasby DJ, Dean DL (2006) Newborn screening for lysosomal storage disorders. Mol Genet Metab 88:307–314PubMedCrossRef Moyer V, Calonge N, Teutsch S, Botkin J (2008) Expanding newborn screening: process, policy, and priorities. Hast Cent Rep 38:32–39CrossRef National Health Committee (2003) Screening to improve Health in New Zealand: criteria to assess screening programmes. National Health Committee, Wellington National Testing Centre (2010) Newborn baby metabolic screening programme. Annual Report Unpublished Report. p. 51 New Zealand Ministry of Health (2007) Antenatal Down syndrome screening in New Zealand. New Zealand Ministry of Health, Wellington Padilla CD, Krotoski D, Therrell BL Jr (2010) Newborn screening progress in developing countries—overcoming internal barriers. Semin Perinatol 34:145–155PubMedCrossRef Parsons EP, Bradley DM (2008) Newborn screening programmes. In: LS John (ed) http://​www.​els.​net. doi:10.​1002/​9780470015902.​a0005637.

Comments are closed.